0
0
10/18/22 at 12:30pm
Organization
Business Wire
42 words
0
Comments
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the company’s upcoming new data from its HIV research and development programs to be presented at
You are the first to view
https://www.businesswire.com/news/home/20221017005765/en/Gilead-Presents-Real-World-and-Long-Term-Data-From-HIV-Research-Programs-at-HIV-Glasgow-2022
Create an account
or login to join the discussion